{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:15:10Z","timestamp":1791764110622,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.japh.2024.102274","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T07:00:06Z","timestamp":1729753206000},"page":"102274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bridging PrEP access gaps: Mapping geospatial accessibility across the United States and leveraging community pharmacies for expansion"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8414-7303","authenticated-orcid":false,"given":"Jacinda","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4662-0374","authenticated-orcid":false,"given":"Anu","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-8923","authenticated-orcid":false,"given":"Marita","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3887-1242","authenticated-orcid":false,"given":"Ryan","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2024.102274_bib1","year":"2023"},{"issue":"27","key":"10.1016\/j.japh.2024.102274_bib3","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.japh.2024.102274_bib4","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"10013","key":"10.1016\/j.japh.2024.102274_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.japh.2024.102274_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAI.0000000000001129","article-title":"Preexposure prophylaxis for HIV prevention in a Large integrated health care system: adherence, renal safety, and discontinuation","volume":"73","author":"Marcus","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.japh.2024.102274_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.japh.2024.102274_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.japh.2024.102274_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12916-018-1047-1","article-title":"The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco","volume":"16","author":"Shen","year":"2018","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.japh.2024.102274_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-156-8-201204170-00001","article-title":"The cost-effectiveness of preexposure prophylaxis for HIV prevention in men who have sex with men in the United States","volume":"156","author":"Juusola","year":"2012","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/cid\/ciw578","article-title":"A\u00a0cost-effectiveness analysis of preexposure prophylaxis for the prevention of HIV among Los Angeles county men who have sex with men","volume":"63","author":"Drabo","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.japh.2024.102274_bib12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1080\/09540121.2017.1417528","article-title":"Can we afford to offer pre-exposure prophylaxis to MSM in Catalonia? Cost-effectiveness analysis and budget impact assessment","volume":"30","author":"Reyes-Urue\u00f1a","year":"2018","journal-title":"AIDS Care"},{"issue":"7","key":"10.1016\/j.japh.2024.102274_bib13","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.7.1800398","article-title":"Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058","volume":"24","author":"van de Vijver","year":"2019","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12889-020-8334-4","article-title":"Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel","volume":"20","author":"Ginsberg","year":"2020","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.japh.2024.102274_bib15","year":"2022","journal-title":"Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data): national HIV Surveillance System data reported through June 2022; and preexposure prophylaxis (PrEP) data reported through March 2022 3(3)"},{"issue":"4","key":"10.1016\/j.japh.2024.102274_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/aje\/kwy230","article-title":"Addressing gaps in HIV preexposure prophylaxis care to reduce racial disparities in HIV incidence in the United States","volume":"188","author":"Jenness","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.japh.2024.102274_bib17","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1016\/S2352-3018(21)00147-8","article-title":"Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities","volume":"8","author":"Quan","year":"2021","journal-title":"The Lancet HIV"},{"issue":"3","key":"10.1016\/j.japh.2024.102274_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283764","article-title":"Ending the HIV epidemic PrEP equity recommendations from a rapid ethnographic assessment of multilevel PrEP use determinants among young black gay and bisexual men in Atlanta, GA","volume":"18","author":"Hill","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.japh.2024.102274_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1377\/hlthaff.2022.00523","article-title":"Estimated uncovered costs for HIV preexposure prophylaxis in the US, 2018","volume":"42","author":"Bonacci","year":"2023","journal-title":"Health Aff"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib20","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1007\/s10461-018-2067-8","article-title":"Facilitators and barriers to pre-exposure prophylaxis (PrEP) Use among black individuals in the United States: results from the national survey on HIV in the black community (NSHBC)","volume":"22","author":"Ojikutu","year":"2018","journal-title":"AIDS Behav"},{"issue":"6","key":"10.1016\/j.japh.2024.102274_bib21","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s10508-020-01654-6","article-title":"Facilitators and barriers of pre-exposure prophylaxis (PrEP) uptake among rural men who have sex with men living in the Midwestern U.S","volume":"49","author":"Owens","year":"2020","journal-title":"Arch Sex Behav"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/09540121.2017.1300633","article-title":"Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts","volume":"29","author":"Cahill","year":"2017","journal-title":"AIDS Care"},{"issue":"14","key":"10.1016\/j.japh.2024.102274_bib23","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.3390\/ijerph19148431","article-title":"Tennessee pharmacists\u2019 opinions on barriers and facilitators to initiate PrEP: a qualitative study","volume":"19","author":"Cernasev","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"10.1016\/j.japh.2024.102274_bib24","first-page":"730","article-title":"Stigma, partners, providers and costs: potential barriers to PrEP uptake among US Women","volume":"8","author":"Goparaju","year":"2017","journal-title":"J\u00a0AIDS Clin Res"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10461-020-02951-w","article-title":"A\u00a0tale of two cities: exploring the role of race\/ethnicity and geographic setting on PrEP use among adolescent cisgender MSM","volume":"25","author":"Saleska","year":"2021","journal-title":"AIDS Behav"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1089\/apc.2017.0171","article-title":"Potential healthcare insurance and provider barriers to pre-exposure prophylaxis utilization among young men who have sex with men","volume":"31","author":"Marks","year":"2017","journal-title":"AIDS Patient Care STDS"},{"issue":"12","key":"10.1016\/j.japh.2024.102274_bib27","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.annepidem.2018.05.006","article-title":"Location location location: an exploration of disparities in access to publicly listed PrEP clinics in the United States","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"2","key":"10.1016\/j.japh.2024.102274_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s10903-022-01412-x","article-title":"Geographic disparities in availability of Spanish-language PrEP services among latino sexual minority men in South Florida","volume":"25","author":"Shrader","year":"2023","journal-title":"J\u00a0Immigr Minor Health"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/09540121.2022.2029816","article-title":"\u201cDo I want PrEP or do I want a roof?\u201d: social determinants of health and HIV prevention in the southern United States","volume":"34","author":"Harrison","year":"2022","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.japh.2024.102274_bib30","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s10461-019-02722-2","article-title":"Demographic, behavioral, and geographic differences between men, transmen, and transwomen currently on PrEP, former PrEP users, and those having never used PrEP","volume":"24","author":"Westmoreland","year":"2020","journal-title":"AIDS Behav"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013059","article-title":"Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review","volume":"6","author":"Kelly","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.japh.2024.102274_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.sste.2018.08.001","article-title":"Distance to HIV care and treatment adherence: adjusting for socio-demographic and geographical heterogeneity","volume":"27","author":"Amram","year":"2018","journal-title":"Spat Spatiotemporal Epidemiol"},{"issue":"10","key":"10.1016\/j.japh.2024.102274_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185699","article-title":"Distance to care, enrollment and loss to follow-up of HIV patients during decentralization of antiretroviral therapy in Neno District, Malawi: A retrospective cohort study","volume":"12","author":"Bilinski","year":"2017","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.japh.2024.102274_bib34","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.19.00175","article-title":"Impact of travel time on health care costs and resource use by phase of care for older patients with cancer","volume":"37","author":"Rocque","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.japh.2024.102274_bib35","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2105\/AJPH.2019.305172","article-title":"Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States","volume":"109","author":"Siegler","year":"2019","journal-title":"Am J Public Health"},{"key":"10.1016\/j.japh.2024.102274_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.annepidem.2021.09.006","article-title":"The spatiotemporal distribution of pre-exposure prophylaxis accessibility in the United States, 2016\u20132020","volume":"64","author":"Sharpe","year":"2021","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib37","doi-asserted-by":"crossref","DOI":"10.2196\/12405","article-title":"Spatial access and willingness to Use pre-exposure prophylaxis among black\/African American individuals in the United States: cross-sectional survey","volume":"5","author":"Ojikutu","year":"2019","journal-title":"JMIR Public Health Surveill"},{"issue":"Suppl 2","key":"10.1016\/j.japh.2024.102274_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10461-021-03249-1","article-title":"Geographic density and uptake of pre-exposure prophylaxis (PrEP) among young gay, bisexual and other sexual minority men: a global positioning system (GPS) study","volume":"25","author":"Kim","year":"2021","journal-title":"AIDS Behav"},{"key":"10.1016\/j.japh.2024.102274_bib39","doi-asserted-by":"crossref","DOI":"10.5888\/pcd17.200317","article-title":"Community pharmacists\u2019 contributions to disease management during the COVID-19 pandemic","volume":"17","author":"Strand","year":"2020","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.japh.2024.102274_bib40","series-title":"Community Pharmacy: The Face of Neighborhood Health Care in America","year":"2015"},{"key":"10.1016\/j.japh.2024.102274_bib41","series-title":"The Rx Report: A New Day in Retail Pharmacy","year":"2022"},{"issue":"6","key":"10.1016\/j.japh.2024.102274_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1071\/SH18084","article-title":"Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care","volume":"15","author":"Tung","year":"2018","journal-title":"Sex Health"},{"issue":"5","key":"10.1016\/j.japh.2024.102274_bib43","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10461-021-03494-4","article-title":"Pharmacy-based Interventions to increase Use of HIV pre-exposure prophylaxis in the United States: a scoping review","volume":"26","author":"Zhao","year":"2022","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco department of public health","volume":"60","author":"Lopez","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"10","key":"10.1016\/j.japh.2024.102274_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.japh.2024.102274_bib46","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/jac5.1667","article-title":"Implementation of pharmacist-led HIV pre-exposure prophylaxis management to increase access to care at an academic internal medicine practice","volume":"5","author":"Miller","year":"2022","journal-title":"J\u00a0Am Coll Clin Pharm"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2019.0235","article-title":"A\u00a0pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation","volume":"34","author":"Khosropour","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.japh.2024.102274_bib50","author":"Collins"},{"key":"10.1016\/j.japh.2024.102274_bib51","author":"Wells"},{"issue":"10","key":"10.1016\/j.japh.2024.102274_bib52","first-page":"39","article-title":"Supporting provider status for pharmacists","volume":"48","author":"Terrie","year":"2023","journal-title":"US Pharm"},{"issue":"10","key":"10.1016\/j.japh.2024.102274_bib57","doi-asserted-by":"crossref","DOI":"10.2196\/23173","article-title":"A\u00a0data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource","volume":"22","author":"Sullivan","year":"2020","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.japh.2024.102274_bib58","author":"Krieger"},{"key":"10.1016\/j.japh.2024.102274_bib61","article-title":"Mapping healthcare deserts","author":"Nguyen","year":"2021","journal-title":"GoodRx Res"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-022-00183-8","article-title":"Spatial modeling of vaccine deserts as barriers to controlling SARS-CoV-2","volume":"2","author":"Rader","year":"2022","journal-title":"Commun Med"},{"issue":"3","key":"10.1016\/j.japh.2024.102274_bib63","article-title":"A\u00a0systematic review of food deserts, 1966-2007","volume":"6","author":"Beaulac","year":"2009","journal-title":"Prev Chronic Dis"},{"issue":"6","key":"10.1016\/j.japh.2024.102274_bib64","first-page":"1875","article-title":"Pharmacy deserts: more than where pharmacies are","volume":"62","author":"Ying","year":"2022","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"4","key":"10.1016\/j.japh.2024.102274_bib66","first-page":"948","article-title":"Association between the geographic accessibility of PrEP and PrEP use among MSM in nonurban areas","volume":"38","author":"Sharpe","year":"2022","journal-title":"J\u00a0Rural Health"},{"key":"10.1016\/j.japh.2024.102274_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-072X-7-3","article-title":"Estimating the accuracy of geographical imputation","volume":"7","author":"Henry","year":"2008","journal-title":"Int J Health Geogr"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib69","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1377\/hlthaff.2013.1397","article-title":"\u2018Pharmacy deserts\u2019 are prevalent in Chicago\u2019s predominantly minority communities, raising medication access concerns","volume":"33","author":"Qato","year":"2014","journal-title":"Health Aff"},{"key":"10.1016\/j.japh.2024.102274_bib70","doi-asserted-by":"crossref","first-page":"100227","DOI":"10.1016\/j.jvacx.2022.100227","article-title":"Pharmacy deserts and COVID-19 risk at the census tract level in the State of Washington","volume":"12","author":"Wittenauer","year":"2022","journal-title":"Vaccine X"},{"issue":"7","key":"10.1016\/j.japh.2024.102274_bib71","doi-asserted-by":"crossref","first-page":"e2326028","DOI":"10.1001\/jamanetworkopen.2023.26028","article-title":"Examination of HIV preexposure prophylaxis need, availability, and potential pharmacy integration in the Southeastern US","volume":"6","author":"Harrington","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.japh.2024.102274_bib72","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","article-title":"The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis\u2013to-need ratio in the fourth quarter of 2017, United States","volume":"28","author":"Siegler","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"3","key":"10.1016\/j.japh.2024.102274_bib76","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/QAI.0000000000002774","article-title":"Trends in the number and characteristics of HIV preexposure prophylaxis providers in the United States, 2014\u20132019","volume":"88","author":"Zhu","year":"2021","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.japh.2024.102274_bib77","doi-asserted-by":"crossref","first-page":"689927","DOI":"10.3389\/fonc.2021.689927","article-title":"Disparity in access to oncology precision care: a geospatial analysis of driving distances to genetic counselors in the U.S","volume":"11","author":"Bellaiche","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.japh.2024.102274_bib78","doi-asserted-by":"crossref","first-page":"102297","DOI":"10.1016\/j.pmedr.2023.102297","article-title":"Travel for medical or dental care by race\/ethnicity and rurality in the U.S.: findings from the 2001, 2009 and 2017 national household travel surveys","volume":"35","author":"Akinlotan","year":"2023","journal-title":"Prev Med Rep"},{"issue":"2","key":"10.1016\/j.japh.2024.102274_bib79","first-page":"476","article-title":"Access to community pharmacies based on drive time and by rurality across the contiguous United States","volume":"64","author":"Sharareh","year":"2024","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"8","key":"10.1016\/j.japh.2024.102274_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183172","article-title":"The availability of pharmacies in the United States: 2007\u20132015","volume":"12","author":"Qato","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10995-015-1820-0","article-title":"Factors associated with travel time and distance to access hospital care among Infants with Spina Bifida","volume":"20","author":"Radcliff","year":"2016","journal-title":"Matern Child Health J"},{"issue":"10","key":"10.1016\/j.japh.2024.102274_bib82","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/COC.0000000000000944","article-title":"Regional variation in access to oncologic care and racial disparities among cervical cancer patients","volume":"45","author":"Alimena","year":"2022","journal-title":"Am J Clin Oncol"},{"issue":"37","key":"10.1016\/j.japh.2024.102274_bib83","doi-asserted-by":"crossref","first-page":"801","DOI":"10.15585\/mmwr.mm6837a2","article-title":"Racial\/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men \u2014 23 urban areas, 2017","volume":"68","author":"Kanny","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.japh.2024.102274_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab293","article-title":"Worsening disparities in state-level uptake of human immunodeficiency virus preexposure prophylaxis, 2014\u20132018","volume":"8","author":"Powers","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.japh.2024.102274_bib85","doi-asserted-by":"crossref","first-page":"e25286","DOI":"10.1002\/jia2.25286","article-title":"Suboptimal geographic accessibility to comprehensive HIV care in the US: regional and urban\u2013rural differences","volume":"22","author":"Masiano","year":"2019","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"7","key":"10.1016\/j.japh.2024.102274_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270404","article-title":"Spatial accessibility to HIV testing, treatment, and prevention services in Illinois and Chicago, USA","volume":"17","author":"Kang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.japh.2024.102274_bib87","author":"Hung"},{"issue":"8","key":"10.1016\/j.japh.2024.102274_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237269","article-title":"County-level factors affecting Latino HIV disparities in the United States","volume":"15","author":"Benbow","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.japh.2024.102274_bib89","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1007\/s40615-022-01456-7","article-title":"A\u00a0census tract\u2013level Examination of diagnosed HIV infection and social vulnerability among black\/African American, Hispanic\/Latino, and white adults, 2018: United States","volume":"10","author":"Gant","year":"2023","journal-title":"J\u00a0Racial Ethn Health Disparities"},{"issue":"2","key":"10.1016\/j.japh.2024.102274_bib90","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0033354921990373","article-title":"A\u00a0census tract\u2013level Examination of differences in social determinants of health among people with HIV, by race\/ethnicity and geography, United States and Puerto Rico, 2017","volume":"137","author":"Johnson Lyons","year":"2022","journal-title":"Public Health Rep"},{"issue":"9","key":"10.1016\/j.japh.2024.102274_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107701","article-title":"A\u00a0census tract\u2013level Examination of social determinants of health among black\/African American men with diagnosed HIV infection, 2005\u20132009\u201417 US areas","volume":"9","author":"Gant","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.japh.2024.102274_bib92","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11606-022-07687-y","article-title":"Examining the correlation between PrEP Use and black:white disparities in HIV incidence in the ending the HIV epidemic priority jurisdictions","volume":"38","author":"Bunting","year":"2023","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.japh.2024.102274_bib93","author":"Lam"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pharmacy11010009","article-title":"A\u00a0Qualitative systematic literature review of the Role of U.S. Pharmacists in prescribing pre-exposure prophylaxis (PrEP)","volume":"11","author":"Cernasev","year":"2023","journal-title":"Pharmacy (Basel)"},{"issue":"4","key":"10.1016\/j.japh.2024.102274_bib95","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.japh.2019.12.003","article-title":"Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men","volume":"60","author":"Crawford","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.japh.2024.102274_bib96","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0897190020904590","article-title":"Willingness to discuss and screen for pre-exposure prophylaxis in pharmacies among men who have sex with men","volume":"34","author":"Crawford","year":"2021","journal-title":"J\u00a0Pharm Pract"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207372","article-title":"Midwest pharmacists\u2019 familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV","volume":"13","author":"Broekhuis","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib98","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/clinpract13010025","article-title":"Empowering Tennessee pharmacists to initiate PrEP using collaborative pharmacy practice agreements","volume":"13","author":"Cernasev","year":"2023","journal-title":"Clin Pract"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib99","first-page":"115","article-title":"Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: examining concordance between pharmacy technicians and pharmacists","volume":"61","author":"Hopkins","year":"2021","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"4","key":"10.1016\/j.japh.2024.102274_bib100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jac5.1773","article-title":"A\u00a0survey of South Carolina pharmacists\u2019 readiness to prescribe human immunodeficiency virus pre-exposure prophylaxis","volume":"6","author":"Burns","year":"2023","journal-title":"J\u00a0Am Coll Clin Pharm"},{"issue":"2","key":"10.1016\/j.japh.2024.102274_bib101","first-page":"547","article-title":"Examining pharmacies\u2019 ability to increase pre-exposure prophylaxis access for black men who have sex with men in the United States","volume":"63","author":"Alohan","year":"2023","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"2","key":"10.1016\/j.japh.2024.102274_bib102","first-page":"e75","article-title":"Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: a survey of patients receiving antiretroviral therapy","volume":"61","author":"Lutz","year":"2021","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"6","key":"10.1016\/j.japh.2024.102274_bib103","first-page":"781","article-title":"Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention","volume":"60","author":"Zhu","year":"2020","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"1","key":"10.1016\/j.japh.2024.102274_bib104","first-page":"370","article-title":"An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay area pharmacies","volume":"62","author":"Bellman","year":"2022","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"11","key":"10.1016\/j.japh.2024.102274_bib105","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad549","article-title":"Opportunities to increase access to HIV prevention: evaluating the implementation of pharmacist-Initiated pre-exposure prophylaxis in California","volume":"10","author":"Hunter","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.japh.2024.102274_bib106","first-page":"e179","article-title":"Attitudes about community pharmacy access to HIV prevention medications in California","volume":"60","author":"Koester","year":"2020","journal-title":"J\u00a0Am Pharmaceut Assoc"},{"issue":"3","key":"10.1016\/j.japh.2024.102274_bib108","doi-asserted-by":"crossref","first-page":"e26232","DOI":"10.1002\/jia2.26232","article-title":"Facilitators and barriers to community pharmacy PrEP delivery: a scoping review","volume":"27","author":"Harrison","year":"2024","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"7","key":"10.1016\/j.japh.2024.102274_bib111","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.25291","article-title":"Disparities in travel-related barriers to accessing health care from the 2017 national household travel survey","volume":"6","author":"Labban","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124003054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124003054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:38:39Z","timestamp":1741653519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124003054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1544319124003054"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102274","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging PrEP access gaps: Mapping geospatial accessibility across the United States and leveraging community pharmacies for expansion","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102274"}}